Xifaxan Salix Pharmaceuticals, Ltd - Treatment for Travelers’ Diarrhea
Xifaxan is a nonsystemic gastrointestinal-selective, oral antibiotic indicated for the treatment of patients (12 years of age and older) with traveler's diarrhea caused by noninvasive strains of Escherichia coli.Posted: May 2004
Related articles
- FDA Approves Xifaxan (rifaximin) for the Treatment of IBS-D (Irritable Bowel Syndrome with Diarrhea) - May 27, 2015
- FDA Approves New Use of Xifaxan for Patients with Liver Disease - March 25, 2010
Xifaxan (rifaximin) FDA Approval History
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.